Group 1: IPO Market Overview - Since 2025, the Hong Kong stock market has seen 86 new IPOs, raising approximately 2508.84 million HKD [1] - In the past week (November 16 to November 22), there was 1 listing, 3 companies in the IPO process, 4 companies undergoing hearings, and 6 companies that submitted applications [1][2] - The average issuance market value of the last 10 new listings is 631.20 million HKD, with an average PE ratio of 28.72 [23] Group 2: Recent IPOs - Zhongwei New Materials (2698.HK) successfully listed on the Hong Kong Stock Exchange on November 17, with a first-day closing price down 0.12% and a total market value of 353.95 million HKD [4][3] - The stock price of Zhongwei New Materials has dropped 16% in its first week of trading [1] - The average first-day increase for recent IPOs is 40.38%, indicating a cooling trend in the AH new stock market [23] Group 3: Upcoming IPOs - Three companies, including Innovation Industry, Quantitative Group, and Haiwei Co., are currently in the IPO process, with expected listing dates between November 24 and November 28, 2025 [5][9] - Innovation Industry completed its IPO with a subscription ratio exceeding 3600 times, indicating strong investor interest [8] - Haiwei Co. has a subscription ratio exceeding 800 times as of November 23, 2025 [10] Group 4: Companies Undergoing Hearings - Four companies passed hearings in the past week, including Naxin Microelectronics, LeMo Technology, Yujian Xiaomian, and Jinyan High-tech [11][12][13][15] - Naxin Microelectronics reported a revenue of 1.524 billion RMB in the first half of 2025, with a year-on-year growth of 80% [11] - LeMo Technology's revenue for 2024 was nearly 800 million RMB, with a growth of 36% [12] Group 5: Companies Submitting Applications - Six companies submitted applications to the Hong Kong Stock Exchange, including Liying Intelligent Manufacturing, Mandi International, and others [16] - Liying Intelligent Manufacturing reported a revenue of 44.26 billion RMB in 2024, with a year-on-year growth of nearly 30% [17] - Mandi International, a spin-off from Sanofi Pharmaceutical, reported a revenue of 1.455 billion RMB in 2024, with a growth of nearly 20% [18]

来源：直通IPO；文/邵延港 招股书显示，在领益智造的股权机构中，曾芳琴直接持股1.98%，间接透过全资持有的领胜投资控制领益智造56.66%的股份，合计持有股权比例为58.64%。 按照领益智造约950亿元的市值计算，曾芳勤持股市值约557亿元。在《2025胡润女企业家榜》中，曾芳勤以695亿元财富位居第六，跻身中国最成功的女性 企业家行列。 领益智造是全球领先的AI硬件智能制造平台，专注于为全球客户提供一站式智能制造服务及解决方案。公司构建从核心材料、精密功能件、模块到精品组 装的一体化解决方案平台能力，产品广泛应用于AI硬件（涵盖AI终端设备、机器人及企业级商用服务器）、汽车以及低空经济等核心前沿领域。 根据弗若斯特沙利文资料，以2024年收入计，领益智造在全球AI终端设备高精密功能件市场行业中排名第一，在全球AI终端设备高精密智能制造平台行业 中排名第三。 随着全球AI技术在各领域快速落地，领益智造精准卡位硬件关键节点，在人－人形机器人、眼－AI眼镜及XR设备、折－折迭屏设备、服－服务器等战略聚 焦的四大新兴应用领域形成多赛道协同优势，构建起多场景的增长格局。 市值近千亿的制造业龙头，正式冲刺"A+H ...